Study of lung immune cells and the gut microbiome
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You do not have an immune system problem (immune deficiency)
- You do not have a known lung disease
- You do not currently have cancer or an active infection
- A bronchoscopy is medically safe for you (no major safety reasons to avoid it)
- You do not have serious heart rhythm problems, known/suspected high brain pressure, need one-lung ventilation, or severe bleeding/clotting problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
This study explores how the immune system and lung microbes affect children with lung disease. It uses extra fluid collected during a standard lung exam to look for new treatment targets.
This study looks at different lung immune cell patterns and how they work in smokers who are not yet diagnosed with COPD or asthma. It may help researchers understand why some people are more likely to develop COPD, which could guide future prevention or early treatments.
This study uses a lung wash (bronchoalveolar lavage) to look at the types of immune cells in the lungs of people with certain lung scarring diseases called interstitial lung diseases (ILD). It may help doctors better understand different ILD types and guide treatment.
This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.
This study looks at how the body’s “innate” (first-line) immune system works in people with COPD compared with healthy volunteers. It may help researchers understand COPD inflammation and how immune responses could be targeted in the future.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.